nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Topotecan—lung cancer	0.08	0.142	CbGbCtD
Sufentanil—CYP3A4—Gefitinib—lung cancer	0.0731	0.13	CbGbCtD
Sufentanil—CYP3A4—Teniposide—lung cancer	0.0709	0.126	CbGbCtD
Sufentanil—CYP3A4—Vinorelbine—lung cancer	0.0563	0.1	CbGbCtD
Sufentanil—CYP3A4—Crizotinib—lung cancer	0.0448	0.0796	CbGbCtD
Sufentanil—CYP3A4—Erlotinib—lung cancer	0.0432	0.0768	CbGbCtD
Sufentanil—CYP3A4—Paclitaxel—lung cancer	0.0396	0.0703	CbGbCtD
Sufentanil—CYP3A4—Irinotecan—lung cancer	0.039	0.0694	CbGbCtD
Sufentanil—CYP3A4—Vinblastine—lung cancer	0.0347	0.0617	CbGbCtD
Sufentanil—CYP3A4—Etoposide—lung cancer	0.0313	0.0556	CbGbCtD
Sufentanil—CYP3A4—Docetaxel—lung cancer	0.0286	0.0508	CbGbCtD
Sufentanil—CYP3A4—Doxorubicin—lung cancer	0.0213	0.0379	CbGbCtD
Sufentanil—Cardiac arrest—Topotecan—lung cancer	0.0029	0.00895	CcSEcCtD
Sufentanil—Hypertension—Pemetrexed—lung cancer	0.00264	0.00815	CcSEcCtD
Sufentanil—Chills—Teniposide—lung cancer	0.00255	0.00788	CcSEcCtD
Sufentanil—Arrhythmia—Teniposide—lung cancer	0.00254	0.00785	CcSEcCtD
Sufentanil—Anaphylactic shock—Pemetrexed—lung cancer	0.0025	0.0077	CcSEcCtD
Sufentanil—Urinary incontinence—Paclitaxel—lung cancer	0.00233	0.0072	CcSEcCtD
Sufentanil—Hypotension—Gefitinib—lung cancer	0.00232	0.00715	CcSEcCtD
Sufentanil—Bronchospasm—Vinorelbine—lung cancer	0.00222	0.00684	CcSEcCtD
Sufentanil—Body temperature increased—Crizotinib—lung cancer	0.00216	0.00666	CcSEcCtD
Sufentanil—Hypertension—Teniposide—lung cancer	0.00214	0.0066	CcSEcCtD
Sufentanil—Urinary tract disorder—Erlotinib—lung cancer	0.00206	0.00636	CcSEcCtD
Sufentanil—Urethral disorder—Erlotinib—lung cancer	0.00205	0.00631	CcSEcCtD
Sufentanil—Cardiac arrest—Irinotecan—lung cancer	0.00205	0.00631	CcSEcCtD
Sufentanil—Confusional state—Teniposide—lung cancer	0.00204	0.00629	CcSEcCtD
Sufentanil—Tachycardia—Teniposide—lung cancer	0.00197	0.00609	CcSEcCtD
Sufentanil—Body temperature increased—Pemetrexed—lung cancer	0.00197	0.00609	CcSEcCtD
Sufentanil—Body temperature increased—Gefitinib—lung cancer	0.00196	0.00605	CcSEcCtD
Sufentanil—Chills—Topotecan—lung cancer	0.00189	0.00584	CcSEcCtD
Sufentanil—Hypotension—Teniposide—lung cancer	0.00189	0.00583	CcSEcCtD
Sufentanil—Chills—Erlotinib—lung cancer	0.00187	0.00578	CcSEcCtD
Sufentanil—Arrhythmia—Erlotinib—lung cancer	0.00186	0.00575	CcSEcCtD
Sufentanil—Hypersensitivity—Pemetrexed—lung cancer	0.00184	0.00568	CcSEcCtD
Sufentanil—Hypersensitivity—Gefitinib—lung cancer	0.00183	0.00564	CcSEcCtD
Sufentanil—Erythema—Erlotinib—lung cancer	0.00182	0.00561	CcSEcCtD
Sufentanil—Dizziness—Crizotinib—lung cancer	0.00181	0.00557	CcSEcCtD
Sufentanil—Bronchospasm—Gemcitabine—lung cancer	0.00178	0.0055	CcSEcCtD
Sufentanil—Pruritus—Pemetrexed—lung cancer	0.00177	0.00545	CcSEcCtD
Sufentanil—Pruritus—Gefitinib—lung cancer	0.00175	0.00542	CcSEcCtD
Sufentanil—Apnoea—Methotrexate—lung cancer	0.00174	0.00538	CcSEcCtD
Sufentanil—Vomiting—Crizotinib—lung cancer	0.00174	0.00536	CcSEcCtD
Sufentanil—Rash—Crizotinib—lung cancer	0.00172	0.00532	CcSEcCtD
Sufentanil—Dermatitis—Crizotinib—lung cancer	0.00172	0.00531	CcSEcCtD
Sufentanil—Cardiac arrest—Etoposide—lung cancer	0.0017	0.00525	CcSEcCtD
Sufentanil—Cardiac arrest—Paclitaxel—lung cancer	0.00167	0.00515	CcSEcCtD
Sufentanil—Feeling abnormal—Teniposide—lung cancer	0.00167	0.00514	CcSEcCtD
Sufentanil—Dizziness—Pemetrexed—lung cancer	0.00165	0.00509	CcSEcCtD
Sufentanil—Hypertension—Vinblastine—lung cancer	0.00163	0.00504	CcSEcCtD
Sufentanil—Nausea—Crizotinib—lung cancer	0.00162	0.00501	CcSEcCtD
Sufentanil—Arrhythmia—Vinorelbine—lung cancer	0.00161	0.00498	CcSEcCtD
Sufentanil—Body temperature increased—Teniposide—lung cancer	0.0016	0.00493	CcSEcCtD
Sufentanil—Vomiting—Pemetrexed—lung cancer	0.00159	0.0049	CcSEcCtD
Sufentanil—Vomiting—Gefitinib—lung cancer	0.00158	0.00487	CcSEcCtD
Sufentanil—Rash—Pemetrexed—lung cancer	0.00157	0.00486	CcSEcCtD
Sufentanil—Dermatitis—Pemetrexed—lung cancer	0.00157	0.00485	CcSEcCtD
Sufentanil—Erythema—Vinorelbine—lung cancer	0.00157	0.00485	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—lung cancer	0.00157	0.00483	CcSEcCtD
Sufentanil—Rash—Gefitinib—lung cancer	0.00156	0.00483	CcSEcCtD
Sufentanil—Dermatitis—Gefitinib—lung cancer	0.00156	0.00482	CcSEcCtD
Sufentanil—Bronchospasm—Etoposide—lung cancer	0.00152	0.0047	CcSEcCtD
Sufentanil—Bradycardia—Irinotecan—lung cancer	0.00151	0.00468	CcSEcCtD
Sufentanil—Anaphylactic shock—Topotecan—lung cancer	0.0015	0.00463	CcSEcCtD
Sufentanil—Hypersensitivity—Teniposide—lung cancer	0.00149	0.0046	CcSEcCtD
Sufentanil—Nausea—Pemetrexed—lung cancer	0.00148	0.00458	CcSEcCtD
Sufentanil—Nausea—Gefitinib—lung cancer	0.00147	0.00455	CcSEcCtD
Sufentanil—Urinary tract disorder—Gemcitabine—lung cancer	0.00143	0.00442	CcSEcCtD
Sufentanil—Pruritus—Teniposide—lung cancer	0.00143	0.00441	CcSEcCtD
Sufentanil—Urethral disorder—Gemcitabine—lung cancer	0.00142	0.00439	CcSEcCtD
Sufentanil—Bradycardia—Cisplatin—lung cancer	0.00138	0.00425	CcSEcCtD
Sufentanil—Hypertension—Vinorelbine—lung cancer	0.00136	0.00419	CcSEcCtD
Sufentanil—Alfentanil—ALB—lung cancer	0.00135	0.434	CrCbGaD
Sufentanil—Chills—Irinotecan—lung cancer	0.00134	0.00412	CcSEcCtD
Sufentanil—Urinary tract disorder—Cisplatin—lung cancer	0.00133	0.00412	CcSEcCtD
Sufentanil—Arrhythmia—Irinotecan—lung cancer	0.00133	0.0041	CcSEcCtD
Sufentanil—Urethral disorder—Cisplatin—lung cancer	0.00132	0.00409	CcSEcCtD
Sufentanil—Chills—Gemcitabine—lung cancer	0.0013	0.00401	CcSEcCtD
Sufentanil—Arrhythmia—Gemcitabine—lung cancer	0.00129	0.004	CcSEcCtD
Sufentanil—Alfentanil—ABCB1—lung cancer	0.00129	0.414	CrCbGaD
Sufentanil—Vomiting—Teniposide—lung cancer	0.00129	0.00397	CcSEcCtD
Sufentanil—Anaphylactic shock—Vinorelbine—lung cancer	0.00128	0.00396	CcSEcCtD
Sufentanil—Rash—Teniposide—lung cancer	0.00127	0.00393	CcSEcCtD
Sufentanil—Dermatitis—Teniposide—lung cancer	0.00127	0.00393	CcSEcCtD
Sufentanil—Feeling abnormal—Vinblastine—lung cancer	0.00127	0.00392	CcSEcCtD
Sufentanil—Headache—Teniposide—lung cancer	0.00127	0.00391	CcSEcCtD
Sufentanil—Bronchospasm—Docetaxel—lung cancer	0.00126	0.0039	CcSEcCtD
Sufentanil—Erythema—Gemcitabine—lung cancer	0.00126	0.00389	CcSEcCtD
Sufentanil—Tachycardia—Vinorelbine—lung cancer	0.00125	0.00386	CcSEcCtD
Sufentanil—Bradycardia—Paclitaxel—lung cancer	0.00124	0.00381	CcSEcCtD
Sufentanil—Feeling abnormal—Topotecan—lung cancer	0.00123	0.00381	CcSEcCtD
Sufentanil—Urinary tract disorder—Etoposide—lung cancer	0.00122	0.00377	CcSEcCtD
Sufentanil—Urethral disorder—Etoposide—lung cancer	0.00121	0.00375	CcSEcCtD
Sufentanil—Arrhythmia—Cisplatin—lung cancer	0.00121	0.00373	CcSEcCtD
Sufentanil—Nausea—Teniposide—lung cancer	0.0012	0.00371	CcSEcCtD
Sufentanil—Urinary tract disorder—Paclitaxel—lung cancer	0.0012	0.0037	CcSEcCtD
Sufentanil—Hypotension—Vinorelbine—lung cancer	0.0012	0.0037	CcSEcCtD
Sufentanil—Urethral disorder—Paclitaxel—lung cancer	0.00119	0.00367	CcSEcCtD
Sufentanil—Body temperature increased—Topotecan—lung cancer	0.00118	0.00366	CcSEcCtD
Sufentanil—Erythema—Cisplatin—lung cancer	0.00118	0.00363	CcSEcCtD
Sufentanil—Body temperature increased—Erlotinib—lung cancer	0.00117	0.00362	CcSEcCtD
Sufentanil—Hypersensitivity—Vinblastine—lung cancer	0.00114	0.00351	CcSEcCtD
Sufentanil—Hypertension—Irinotecan—lung cancer	0.00112	0.00345	CcSEcCtD
Sufentanil—Chills—Etoposide—lung cancer	0.00111	0.00343	CcSEcCtD
Sufentanil—Hypersensitivity—Topotecan—lung cancer	0.0011	0.00341	CcSEcCtD
Sufentanil—Hypertension—Gemcitabine—lung cancer	0.00109	0.00336	CcSEcCtD
Sufentanil—Chills—Paclitaxel—lung cancer	0.00109	0.00336	CcSEcCtD
Sufentanil—Arrhythmia—Paclitaxel—lung cancer	0.00108	0.00335	CcSEcCtD
Sufentanil—Confusional state—Irinotecan—lung cancer	0.00107	0.00329	CcSEcCtD
Sufentanil—Pruritus—Topotecan—lung cancer	0.00106	0.00327	CcSEcCtD
Sufentanil—Anaphylactic shock—Irinotecan—lung cancer	0.00106	0.00326	CcSEcCtD
Sufentanil—Erythema—Paclitaxel—lung cancer	0.00106	0.00326	CcSEcCtD
Sufentanil—Feeling abnormal—Vinorelbine—lung cancer	0.00106	0.00326	CcSEcCtD
Sufentanil—Pruritus—Erlotinib—lung cancer	0.00105	0.00324	CcSEcCtD
Sufentanil—Anaphylactic shock—Gemcitabine—lung cancer	0.00103	0.00318	CcSEcCtD
Sufentanil—Dizziness—Vinblastine—lung cancer	0.00102	0.00315	CcSEcCtD
Sufentanil—Urinary tract disorder—Docetaxel—lung cancer	0.00102	0.00314	CcSEcCtD
Sufentanil—Body temperature increased—Vinorelbine—lung cancer	0.00101	0.00313	CcSEcCtD
Sufentanil—Urethral disorder—Docetaxel—lung cancer	0.00101	0.00311	CcSEcCtD
Sufentanil—Dizziness—Topotecan—lung cancer	0.000991	0.00306	CcSEcCtD
Sufentanil—Hypotension—Irinotecan—lung cancer	0.000988	0.00305	CcSEcCtD
Sufentanil—Vomiting—Vinblastine—lung cancer	0.000981	0.00303	CcSEcCtD
Sufentanil—Dizziness—Erlotinib—lung cancer	0.00098	0.00303	CcSEcCtD
Sufentanil—Headache—Vinblastine—lung cancer	0.000966	0.00298	CcSEcCtD
Sufentanil—Hypotension—Gemcitabine—lung cancer	0.000962	0.00297	CcSEcCtD
Sufentanil—Anaphylactic shock—Cisplatin—lung cancer	0.00096	0.00296	CcSEcCtD
Sufentanil—Vomiting—Topotecan—lung cancer	0.000953	0.00294	CcSEcCtD
Sufentanil—Rash—Topotecan—lung cancer	0.000945	0.00292	CcSEcCtD
Sufentanil—Hypersensitivity—Vinorelbine—lung cancer	0.000944	0.00292	CcSEcCtD
Sufentanil—Dermatitis—Topotecan—lung cancer	0.000944	0.00291	CcSEcCtD
Sufentanil—Vomiting—Erlotinib—lung cancer	0.000943	0.00291	CcSEcCtD
Sufentanil—Somnolence—Irinotecan—lung cancer	0.00094	0.0029	CcSEcCtD
Sufentanil—Headache—Topotecan—lung cancer	0.000939	0.0029	CcSEcCtD
Sufentanil—Tachycardia—Cisplatin—lung cancer	0.000937	0.00289	CcSEcCtD
Sufentanil—Rash—Erlotinib—lung cancer	0.000935	0.00289	CcSEcCtD
Sufentanil—Dermatitis—Erlotinib—lung cancer	0.000934	0.00288	CcSEcCtD
Sufentanil—Hypertension—Etoposide—lung cancer	0.00093	0.00287	CcSEcCtD
Sufentanil—Headache—Erlotinib—lung cancer	0.000929	0.00287	CcSEcCtD
Sufentanil—Chills—Docetaxel—lung cancer	0.000923	0.00285	CcSEcCtD
Sufentanil—Arrhythmia—Docetaxel—lung cancer	0.000919	0.00284	CcSEcCtD
Sufentanil—Nausea—Vinblastine—lung cancer	0.000916	0.00283	CcSEcCtD
Sufentanil—Somnolence—Gemcitabine—lung cancer	0.000915	0.00283	CcSEcCtD
Sufentanil—Hypertension—Paclitaxel—lung cancer	0.000912	0.00282	CcSEcCtD
Sufentanil—Pruritus—Vinorelbine—lung cancer	0.000907	0.0028	CcSEcCtD
Sufentanil—Hypotension—Cisplatin—lung cancer	0.000897	0.00277	CcSEcCtD
Sufentanil—Erythema—Docetaxel—lung cancer	0.000895	0.00276	CcSEcCtD
Sufentanil—Nausea—Topotecan—lung cancer	0.00089	0.00275	CcSEcCtD
Sufentanil—Confusional state—Etoposide—lung cancer	0.000887	0.00274	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—lung cancer	0.000882	0.00272	CcSEcCtD
Sufentanil—Nausea—Erlotinib—lung cancer	0.000881	0.00272	CcSEcCtD
Sufentanil—Anaphylactic shock—Etoposide—lung cancer	0.000879	0.00271	CcSEcCtD
Sufentanil—Feeling abnormal—Irinotecan—lung cancer	0.000871	0.00269	CcSEcCtD
Sufentanil—Confusional state—Paclitaxel—lung cancer	0.000869	0.00268	CcSEcCtD
Sufentanil—Anaphylactic shock—Paclitaxel—lung cancer	0.000862	0.00266	CcSEcCtD
Sufentanil—Tachycardia—Etoposide—lung cancer	0.000858	0.00265	CcSEcCtD
Sufentanil—Feeling abnormal—Gemcitabine—lung cancer	0.000849	0.00262	CcSEcCtD
Sufentanil—Dizziness—Vinorelbine—lung cancer	0.000848	0.00262	CcSEcCtD
Sufentanil—Tachycardia—Paclitaxel—lung cancer	0.000841	0.0026	CcSEcCtD
Sufentanil—Body temperature increased—Irinotecan—lung cancer	0.000836	0.00258	CcSEcCtD
Sufentanil—Hypotension—Etoposide—lung cancer	0.000822	0.00254	CcSEcCtD
Sufentanil—Vomiting—Vinorelbine—lung cancer	0.000815	0.00252	CcSEcCtD
Sufentanil—Body temperature increased—Gemcitabine—lung cancer	0.000814	0.00251	CcSEcCtD
Sufentanil—Rash—Vinorelbine—lung cancer	0.000808	0.00249	CcSEcCtD
Sufentanil—Dermatitis—Vinorelbine—lung cancer	0.000807	0.00249	CcSEcCtD
Sufentanil—Hypotension—Paclitaxel—lung cancer	0.000806	0.00249	CcSEcCtD
Sufentanil—Headache—Vinorelbine—lung cancer	0.000803	0.00248	CcSEcCtD
Sufentanil—Feeling abnormal—Cisplatin—lung cancer	0.000791	0.00244	CcSEcCtD
Sufentanil—Somnolence—Etoposide—lung cancer	0.000782	0.00241	CcSEcCtD
Sufentanil—Hypersensitivity—Irinotecan—lung cancer	0.000779	0.0024	CcSEcCtD
Sufentanil—Hypertension—Docetaxel—lung cancer	0.000773	0.00239	CcSEcCtD
Sufentanil—Somnolence—Paclitaxel—lung cancer	0.000766	0.00237	CcSEcCtD
Sufentanil—Nausea—Vinorelbine—lung cancer	0.000761	0.00235	CcSEcCtD
Sufentanil—Body temperature increased—Cisplatin—lung cancer	0.000759	0.00234	CcSEcCtD
Sufentanil—Confusional state—Docetaxel—lung cancer	0.000737	0.00227	CcSEcCtD
Sufentanil—Urinary tract disorder—Methotrexate—lung cancer	0.000732	0.00226	CcSEcCtD
Sufentanil—Anaphylactic shock—Docetaxel—lung cancer	0.000731	0.00226	CcSEcCtD
Sufentanil—Pruritus—Gemcitabine—lung cancer	0.000729	0.00225	CcSEcCtD
Sufentanil—Urethral disorder—Methotrexate—lung cancer	0.000727	0.00224	CcSEcCtD
Sufentanil—Feeling abnormal—Etoposide—lung cancer	0.000725	0.00224	CcSEcCtD
Sufentanil—Tachycardia—Docetaxel—lung cancer	0.000713	0.0022	CcSEcCtD
Sufentanil—Feeling abnormal—Paclitaxel—lung cancer	0.00071	0.00219	CcSEcCtD
Sufentanil—Hypersensitivity—Cisplatin—lung cancer	0.000707	0.00218	CcSEcCtD
Sufentanil—Dizziness—Irinotecan—lung cancer	0.000699	0.00216	CcSEcCtD
Sufentanil—Body temperature increased—Etoposide—lung cancer	0.000695	0.00215	CcSEcCtD
Sufentanil—Hypotension—Docetaxel—lung cancer	0.000683	0.00211	CcSEcCtD
Sufentanil—Body temperature increased—Paclitaxel—lung cancer	0.000682	0.0021	CcSEcCtD
Sufentanil—Vomiting—Irinotecan—lung cancer	0.000672	0.00207	CcSEcCtD
Sufentanil—Rash—Irinotecan—lung cancer	0.000667	0.00206	CcSEcCtD
Sufentanil—Dermatitis—Irinotecan—lung cancer	0.000666	0.00206	CcSEcCtD
Sufentanil—Chills—Methotrexate—lung cancer	0.000665	0.00205	CcSEcCtD
Sufentanil—Headache—Irinotecan—lung cancer	0.000662	0.00204	CcSEcCtD
Sufentanil—Vomiting—Gemcitabine—lung cancer	0.000655	0.00202	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—lung cancer	0.000653	0.00202	CcSEcCtD
Sufentanil—Somnolence—Docetaxel—lung cancer	0.00065	0.00201	CcSEcCtD
Sufentanil—Rash—Gemcitabine—lung cancer	0.000649	0.002	CcSEcCtD
Sufentanil—Dermatitis—Gemcitabine—lung cancer	0.000649	0.002	CcSEcCtD
Sufentanil—Hypersensitivity—Etoposide—lung cancer	0.000648	0.002	CcSEcCtD
Sufentanil—Erythema—Methotrexate—lung cancer	0.000645	0.00199	CcSEcCtD
Sufentanil—Headache—Gemcitabine—lung cancer	0.000645	0.00199	CcSEcCtD
Sufentanil—Hypersensitivity—Paclitaxel—lung cancer	0.000635	0.00196	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—lung cancer	0.000634	0.00196	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—lung cancer	0.000629	0.00194	CcSEcCtD
Sufentanil—Nausea—Irinotecan—lung cancer	0.000628	0.00194	CcSEcCtD
Sufentanil—Pruritus—Etoposide—lung cancer	0.000622	0.00192	CcSEcCtD
Sufentanil—Nausea—Gemcitabine—lung cancer	0.000612	0.00189	CcSEcCtD
Sufentanil—Vomiting—Cisplatin—lung cancer	0.00061	0.00188	CcSEcCtD
Sufentanil—Pruritus—Paclitaxel—lung cancer	0.00061	0.00188	CcSEcCtD
Sufentanil—Rash—Cisplatin—lung cancer	0.000605	0.00187	CcSEcCtD
Sufentanil—Dermatitis—Cisplatin—lung cancer	0.000605	0.00187	CcSEcCtD
Sufentanil—Feeling abnormal—Docetaxel—lung cancer	0.000602	0.00186	CcSEcCtD
Sufentanil—Dizziness—Etoposide—lung cancer	0.000581	0.00179	CcSEcCtD
Sufentanil—Body temperature increased—Docetaxel—lung cancer	0.000578	0.00178	CcSEcCtD
Sufentanil—Chills—Doxorubicin—lung cancer	0.000576	0.00178	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—lung cancer	0.000573	0.00177	CcSEcCtD
Sufentanil—Dizziness—Paclitaxel—lung cancer	0.00057	0.00176	CcSEcCtD
Sufentanil—Nausea—Cisplatin—lung cancer	0.00057	0.00176	CcSEcCtD
Sufentanil—Vomiting—Etoposide—lung cancer	0.000559	0.00173	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—lung cancer	0.000559	0.00172	CcSEcCtD
Sufentanil—Rash—Etoposide—lung cancer	0.000554	0.00171	CcSEcCtD
Sufentanil—Dermatitis—Etoposide—lung cancer	0.000554	0.00171	CcSEcCtD
Sufentanil—Headache—Etoposide—lung cancer	0.000551	0.0017	CcSEcCtD
Sufentanil—Vomiting—Paclitaxel—lung cancer	0.000548	0.00169	CcSEcCtD
Sufentanil—Rash—Paclitaxel—lung cancer	0.000544	0.00168	CcSEcCtD
Sufentanil—Dermatitis—Paclitaxel—lung cancer	0.000543	0.00168	CcSEcCtD
Sufentanil—Headache—Paclitaxel—lung cancer	0.00054	0.00167	CcSEcCtD
Sufentanil—Hypersensitivity—Docetaxel—lung cancer	0.000538	0.00166	CcSEcCtD
Sufentanil—Confusional state—Methotrexate—lung cancer	0.000531	0.00164	CcSEcCtD
Sufentanil—Anaphylactic shock—Methotrexate—lung cancer	0.000527	0.00163	CcSEcCtD
Sufentanil—Nausea—Etoposide—lung cancer	0.000522	0.00161	CcSEcCtD
Sufentanil—Pruritus—Docetaxel—lung cancer	0.000517	0.0016	CcSEcCtD
Sufentanil—Nausea—Paclitaxel—lung cancer	0.000512	0.00158	CcSEcCtD
Sufentanil—Hypotension—Methotrexate—lung cancer	0.000492	0.00152	CcSEcCtD
Sufentanil—Dizziness—Docetaxel—lung cancer	0.000483	0.00149	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—lung cancer	0.000482	0.00149	CcSEcCtD
Sufentanil—Fentanyl—ABCB1—lung cancer	0.000471	0.152	CrCbGaD
Sufentanil—Somnolence—Methotrexate—lung cancer	0.000468	0.00145	CcSEcCtD
Sufentanil—Vomiting—Docetaxel—lung cancer	0.000465	0.00143	CcSEcCtD
Sufentanil—Rash—Docetaxel—lung cancer	0.000461	0.00142	CcSEcCtD
Sufentanil—Dermatitis—Docetaxel—lung cancer	0.00046	0.00142	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—lung cancer	0.00046	0.00142	CcSEcCtD
Sufentanil—Headache—Docetaxel—lung cancer	0.000458	0.00141	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—lung cancer	0.000456	0.00141	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—lung cancer	0.000445	0.00137	CcSEcCtD
Sufentanil—Nausea—Docetaxel—lung cancer	0.000434	0.00134	CcSEcCtD
Sufentanil—Feeling abnormal—Methotrexate—lung cancer	0.000434	0.00134	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—lung cancer	0.000426	0.00132	CcSEcCtD
Sufentanil—Body temperature increased—Methotrexate—lung cancer	0.000416	0.00129	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—lung cancer	0.000405	0.00125	CcSEcCtD
Sufentanil—Hypersensitivity—Methotrexate—lung cancer	0.000388	0.0012	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—lung cancer	0.000376	0.00116	CcSEcCtD
Sufentanil—Pruritus—Methotrexate—lung cancer	0.000373	0.00115	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—lung cancer	0.000361	0.00111	CcSEcCtD
Sufentanil—Dizziness—Methotrexate—lung cancer	0.000348	0.00108	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—lung cancer	0.000336	0.00104	CcSEcCtD
Sufentanil—Vomiting—Methotrexate—lung cancer	0.000335	0.00103	CcSEcCtD
Sufentanil—Rash—Methotrexate—lung cancer	0.000332	0.00103	CcSEcCtD
Sufentanil—Dermatitis—Methotrexate—lung cancer	0.000332	0.00102	CcSEcCtD
Sufentanil—Headache—Methotrexate—lung cancer	0.00033	0.00102	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—lung cancer	0.000323	0.000996	CcSEcCtD
Sufentanil—Nausea—Methotrexate—lung cancer	0.000313	0.000966	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—lung cancer	0.000302	0.000931	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—lung cancer	0.00029	0.000895	CcSEcCtD
Sufentanil—Rash—Doxorubicin—lung cancer	0.000288	0.000888	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—lung cancer	0.000287	0.000887	CcSEcCtD
Sufentanil—Headache—Doxorubicin—lung cancer	0.000286	0.000882	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—lung cancer	0.000271	0.000836	CcSEcCtD
Sufentanil—OPRM1—Signaling Pathways—FGF9—lung cancer	5.41e-05	0.000492	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FOXO3—lung cancer	5.36e-05	0.000487	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—RAF1—lung cancer	5.31e-05	0.000482	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—POMC—lung cancer	5.26e-05	0.000477	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAP2K1—lung cancer	5.25e-05	0.000477	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—IL2—lung cancer	5.24e-05	0.000476	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CD—lung cancer	5.22e-05	0.000474	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CB—lung cancer	5.18e-05	0.000471	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JUNB—lung cancer	5.17e-05	0.000469	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLBD1—lung cancer	5.09e-05	0.000463	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AVP—lung cancer	5.02e-05	0.000456	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	5.01e-05	0.000455	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CB—lung cancer	5.01e-05	0.000455	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL8—lung cancer	4.98e-05	0.000453	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ERBB3—lung cancer	4.95e-05	0.00045	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	4.85e-05	0.000441	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1R—lung cancer	4.83e-05	0.000439	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL8—lung cancer	4.81e-05	0.000437	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—POMC—lung cancer	4.77e-05	0.000434	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL2—lung cancer	4.76e-05	0.000432	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HES1—lung cancer	4.75e-05	0.000431	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TERT—lung cancer	4.74e-05	0.000431	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STK11—lung cancer	4.69e-05	0.000426	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD17B10—lung cancer	4.66e-05	0.000423	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—RAF1—lung cancer	4.66e-05	0.000423	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6R—lung cancer	4.66e-05	0.000423	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGFR1—lung cancer	4.61e-05	0.000418	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL2—lung cancer	4.6e-05	0.000418	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CB—lung cancer	4.55e-05	0.000413	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HIF1A—lung cancer	4.54e-05	0.000412	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FOXO3—lung cancer	4.53e-05	0.000411	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	4.44e-05	0.000403	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	4.41e-05	0.0004	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOA1—lung cancer	4.38e-05	0.000398	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—lung cancer	4.37e-05	0.000397	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB3—lung cancer	4.34e-05	0.000394	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KDR—lung cancer	4.34e-05	0.000394	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CKB—lung cancer	4.33e-05	0.000394	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AVP—lung cancer	4.24e-05	0.000385	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	4.23e-05	0.000384	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—lung cancer	4.17e-05	0.000379	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TERT—lung cancer	4.16e-05	0.000378	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1R—lung cancer	4.08e-05	0.000371	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CNDP2—lung cancer	4.07e-05	0.00037	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM2—lung cancer	4.07e-05	0.00037	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	4.07e-05	0.000369	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGFR1—lung cancer	4.04e-05	0.000367	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HES1—lung cancer	4.01e-05	0.000364	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APC—lung cancer	4e-05	0.000363	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KIT—lung cancer	4e-05	0.000363	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CG—lung cancer	4e-05	0.000363	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—NRAS—lung cancer	4e-05	0.000363	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—lung cancer	3.98e-05	0.000361	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTMR3—lung cancer	3.96e-05	0.00036	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGF—lung cancer	3.95e-05	0.000359	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—RAF1—lung cancer	3.94e-05	0.000357	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—lung cancer	3.89e-05	0.000353	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PGAM1—lung cancer	3.86e-05	0.000351	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	3.84e-05	0.000349	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOA1—lung cancer	3.84e-05	0.000349	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK3—lung cancer	3.83e-05	0.000348	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—POMC—lung cancer	3.8e-05	0.000346	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—lung cancer	3.8e-05	0.000346	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BRAF—lung cancer	3.76e-05	0.000341	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6R—lung cancer	3.71e-05	0.000337	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CREBBP—lung cancer	3.71e-05	0.000337	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—lung cancer	3.69e-05	0.000335	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2A7—lung cancer	3.68e-05	0.000335	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB3—lung cancer	3.67e-05	0.000333	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—lung cancer	3.64e-05	0.000331	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SDC4—lung cancer	3.6e-05	0.000327	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAP2K1—lung cancer	3.54e-05	0.000321	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—lung cancer	3.53e-05	0.000321	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TERT—lung cancer	3.52e-05	0.000319	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CD—lung cancer	3.51e-05	0.000319	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—lung cancer	3.5e-05	0.000318	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KIT—lung cancer	3.5e-05	0.000318	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APC—lung cancer	3.5e-05	0.000318	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—NRAS—lung cancer	3.5e-05	0.000318	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	3.48e-05	0.000316	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGF—lung cancer	3.46e-05	0.000315	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—KRAS—lung cancer	3.44e-05	0.000312	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGFR1—lung cancer	3.41e-05	0.00031	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—lung cancer	3.36e-05	0.000305	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK3—lung cancer	3.36e-05	0.000305	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—POMC—lung cancer	3.34e-05	0.000303	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BRAF—lung cancer	3.29e-05	0.000299	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—RRM1—lung cancer	3.28e-05	0.000298	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA3—lung cancer	3.28e-05	0.000298	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6R—lung cancer	3.25e-05	0.000296	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CREBBP—lung cancer	3.25e-05	0.000295	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOA1—lung cancer	3.24e-05	0.000295	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—lung cancer	3.22e-05	0.000292	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—lung cancer	3.19e-05	0.00029	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	3.16e-05	0.000287	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MDM2—lung cancer	3.15e-05	0.000286	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAF1—lung cancer	3.14e-05	0.000285	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ERBB2—lung cancer	3.1e-05	0.000282	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAP2K1—lung cancer	3.1e-05	0.000282	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—B4GALT5—lung cancer	3.09e-05	0.00028	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CD—lung cancer	3.08e-05	0.00028	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MTOR—lung cancer	3.06e-05	0.000278	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CB—lung cancer	3.06e-05	0.000278	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	3.05e-05	0.000277	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—KRAS—lung cancer	3.02e-05	0.000274	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA4—lung cancer	3e-05	0.000273	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APC—lung cancer	2.96e-05	0.000269	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KIT—lung cancer	2.96e-05	0.000269	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—lung cancer	2.96e-05	0.000269	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—NRAS—lung cancer	2.96e-05	0.000269	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—lung cancer	2.94e-05	0.000267	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGF—lung cancer	2.93e-05	0.000266	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA2—lung cancer	2.93e-05	0.000266	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HRAS—lung cancer	2.92e-05	0.000266	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—lung cancer	2.84e-05	0.000258	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK3—lung cancer	2.84e-05	0.000258	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA1—lung cancer	2.82e-05	0.000256	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—POMC—lung cancer	2.82e-05	0.000256	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—lung cancer	2.82e-05	0.000256	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—lung cancer	2.81e-05	0.000255	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—lung cancer	2.8e-05	0.000254	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCC3—lung cancer	2.79e-05	0.000254	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BRAF—lung cancer	2.78e-05	0.000253	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	2.77e-05	0.000252	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MDM2—lung cancer	2.76e-05	0.000251	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAF1—lung cancer	2.75e-05	0.00025	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6R—lung cancer	2.75e-05	0.00025	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CREBBP—lung cancer	2.75e-05	0.000249	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—lung cancer	2.74e-05	0.000249	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JUN—lung cancer	2.74e-05	0.000249	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB2—lung cancer	2.72e-05	0.000247	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKR1C1—lung cancer	2.7e-05	0.000246	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—lung cancer	2.7e-05	0.000245	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CB—lung cancer	2.69e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MTOR—lung cancer	2.69e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—lung cancer	2.66e-05	0.000242	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1A—lung cancer	2.65e-05	0.000241	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTEN—lung cancer	2.65e-05	0.00024	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UGT1A1—lung cancer	2.62e-05	0.000238	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAP2K1—lung cancer	2.62e-05	0.000238	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CD—lung cancer	2.6e-05	0.000237	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—lung cancer	2.58e-05	0.000235	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—lung cancer	2.58e-05	0.000234	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	2.58e-05	0.000234	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HRAS—lung cancer	2.56e-05	0.000233	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KRAS—lung cancer	2.55e-05	0.000232	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GNG11—lung cancer	2.53e-05	0.00023	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EP300—lung cancer	2.52e-05	0.000229	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—lung cancer	2.49e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—lung cancer	2.47e-05	0.000224	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—lung cancer	2.47e-05	0.000224	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—lung cancer	2.45e-05	0.000223	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—lung cancer	2.45e-05	0.000223	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDOA—lung cancer	2.41e-05	0.000219	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—lung cancer	2.4e-05	0.000218	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JUN—lung cancer	2.4e-05	0.000218	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—lung cancer	2.39e-05	0.000217	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—lung cancer	2.37e-05	0.000215	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NRAS—lung cancer	2.36e-05	0.000214	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	2.34e-05	0.000213	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA3—lung cancer	2.34e-05	0.000213	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—lung cancer	2.33e-05	0.000212	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MDM2—lung cancer	2.33e-05	0.000212	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1A—lung cancer	2.33e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAF1—lung cancer	2.32e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTEN—lung cancer	2.32e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB2—lung cancer	2.3e-05	0.000209	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADCY1—lung cancer	2.28e-05	0.000207	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG2—lung cancer	2.28e-05	0.000207	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CB—lung cancer	2.27e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MTOR—lung cancer	2.27e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—lung cancer	2.26e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK3—lung cancer	2.26e-05	0.000205	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HPGDS—lung cancer	2.23e-05	0.000203	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ENO2—lung cancer	2.23e-05	0.000203	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.22e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EP300—lung cancer	2.21e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—lung cancer	2.2e-05	0.0002	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—lung cancer	2.18e-05	0.000198	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HRAS—lung cancer	2.17e-05	0.000197	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTT1—lung cancer	2.16e-05	0.000197	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—lung cancer	2.15e-05	0.000195	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—lung cancer	2.15e-05	0.000195	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2A6—lung cancer	2.14e-05	0.000194	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCLC—lung cancer	2.14e-05	0.000194	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—lung cancer	2.11e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—lung cancer	2.1e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—lung cancer	2.09e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—lung cancer	2.08e-05	0.000189	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—lung cancer	2.08e-05	0.000189	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—lung cancer	2.07e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NRAS—lung cancer	2.07e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KRAS—lung cancer	2.03e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—lung cancer	2.03e-05	0.000185	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ENO1—lung cancer	2.03e-05	0.000184	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JUN—lung cancer	2.03e-05	0.000184	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK3—lung cancer	1.98e-05	0.00018	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—lung cancer	1.97e-05	0.000179	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1A—lung cancer	1.97e-05	0.000179	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTEN—lung cancer	1.96e-05	0.000178	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—lung cancer	1.93e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.91e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—lung cancer	1.89e-05	0.000171	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EP300—lung cancer	1.87e-05	0.00017	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—lung cancer	1.87e-05	0.00017	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2E1—lung cancer	1.82e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—lung cancer	1.82e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—lung cancer	1.81e-05	0.000164	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NQO1—lung cancer	1.8e-05	0.000163	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KRAS—lung cancer	1.78e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.77e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—lung cancer	1.75e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NRAS—lung cancer	1.75e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HRAS—lung cancer	1.73e-05	0.000157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.68e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—lung cancer	1.65e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.64e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—lung cancer	1.63e-05	0.000148	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—STK11—lung cancer	1.62e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—lung cancer	1.58e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—lung cancer	1.53e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HRAS—lung cancer	1.51e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KRAS—lung cancer	1.51e-05	0.000137	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—lung cancer	1.5e-05	0.000136	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAT—lung cancer	1.46e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—lung cancer	1.45e-05	0.000132	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCB1—lung cancer	1.42e-05	0.000129	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TYMS—lung cancer	1.39e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—lung cancer	1.38e-05	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—lung cancer	1.38e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—lung cancer	1.34e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—lung cancer	1.34e-05	0.000121	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1A1—lung cancer	1.31e-05	0.000119	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ERCC2—lung cancer	1.3e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRAS—lung cancer	1.28e-05	0.000116	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—lung cancer	1.23e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—lung cancer	1.13e-05	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA1—lung cancer	1.12e-05	0.000102	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—lung cancer	1.02e-05	9.3e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—POMC—lung cancer	9.75e-06	8.85e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CREBBP—lung cancer	9.49e-06	8.62e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CD—lung cancer	9e-06	8.18e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—lung cancer	8.88e-06	8.07e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CB—lung cancer	7.84e-06	7.13e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—lung cancer	7.77e-06	7.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTEN—lung cancer	6.78e-06	6.16e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—EP300—lung cancer	6.46e-06	5.87e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—lung cancer	4.78e-06	4.34e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—lung cancer	3.91e-06	3.55e-05	CbGpPWpGaD
